Back to Agenda
Session 4C: Mock Review: A Regulatory Perspective
Session Chair(s)
Kristina Vlaovic, MPH
Vice President, Regulatory, Safety and Pharmacovigilance
HALOZYME Inc., United States
Join us as we walk through the review of a typical marketing and sales tool. We'll be discussing the merits and potential pitfalls; emphasizing important questions that should be considered and enabling an interactive session tapping into the expertise of the moderators and audience. This session is intended for professionals who have less than three years of experience, but all are welcome. A few of the topics to be discussed: efficacy analyses, safety presentations, disease education
Speaker(s)
Facilitators:
Laura A. Cooper
Sanofi US, United States
Senior Director, Regulatory Affairs Marketed Products, Oncology
Leah Palmer, PharmD
United States
Consultant, Regulatory Promotion
Have an account?